CEESAY ABRAHAM (Chief Executive Officer) sold 1.5% of their position (8.22K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $327.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/1/2026ACC: 0001193125-26-292519
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-8.22K
Net shares
Net seller
$327.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.34K
Price / share
$39.77
Trade value
$292.06K
% of position
1.3%
6/29/2026
556.25K→548.90K
Common Stock
Direct
Shares
−876.00
Price / share
$40.34
Trade value
$35.34K
% of position
0.2%
6/29/2026
548.90K→548.03K
Total
Net shares
−8.22K
Net value
-$327.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | S · Sale | −7.34K | $39.77 | $292.06K | 1.3% | 556.25K | 548.90K |
| Common Stock Direct | 6/29/2026 | S · Sale | −876.00 | $40.34 | $35.34K | 0.2% | 548.90K | 548.03K |
| Total | −8.22K | -$327.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned81.73K
Common Stock
IndirectShares owned20.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 81.73K | Indirect |
| Common Stock | 20.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported